PARAMEDICS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PARAMEDICS
Largest movements
- Cash +€85,314
up €85,314 (+147.2%), from €57,946 to €143,260
mainly Other debts (+€97,421) and Net result for the year (+€86,158)
- Current investments +€9,000
up €9,000 (+2.6%), from €344,254 to €353,254
- Receivables within one year +€7,003
up €7,003 (+700.3%), from €1,000 to €8,003
- Other debts +€97,421
up €97,421 (+427.1%), from €22,812 to €120,233
- Gross operating margin -€5,322
down €5,322 (-4.5%), from €117,227 to €111,905
- Financial income +€2,100
up €2,100 (+35.0%), from €6,000 to €8,100
- Taxes -€1,900
down €1,900 (-6.3%), from €30,385 to €28,485
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €409,771 | €507,192 | +€97,421 | +23.8% |
| Fixed assets | 21/28 | €6,571 | €2,674 | -€3,897 | -59.3% |
| Tangible fixed assets | 22/27 | €6,571 | €2,674 | -€3,897 | -59.3% |
| Plant, machinery and equipment | 23 | €3,885 | €769 | -€3,116 | -80.2% |
| Furniture and vehicles | 24 | €2,686 | €1,905 | -€781 | -29.1% |
| Current assets | 29/58 | €403,200 | €504,518 | +€101,318 | +25.1% |
| Amounts receivable within one year | 40/41 | €1,000 | €8,003 | +€7,003 | +700.3% |
| Other amounts receivable | 41 | €1,000 | €8,003 | +€7,003 | +700.3% |
| Current investments | 50/53 | €344,254 | €353,254 | +€9,000 | +2.6% |
| Cash at bank and in hand | 54/58 | €57,946 | €143,260 | +€85,314 | +147.2% |
| Total equity and liabilities | 10/49 | €409,771 | €507,192 | +€97,421 | +23.8% |
| Equity | 10/15 | €383,959 | €383,959 | = | 0.0% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Capital | 10 | €1,000 | - | -€1,000 | |
| Issued capital | 100 | €1,000 | - | -€1,000 | |
| Profit (loss) carried forward | 14 | €382,959 | €382,959 | = | 0.0% |
| Amounts payable | 17/49 | €25,812 | €123,233 | +€97,421 | +377.4% |
| Amounts payable within one year | 42/48 | €25,812 | €120,233 | +€94,421 | +365.8% |
| Trade debts | 44 | €3,000 | €0 | -€3,000 | -100.0% |
| Suppliers | 440/4 | €3,000 | €0 | -€3,000 | -100.0% |
| Other amounts payable | 47/48 | €22,812 | €120,233 | +€97,421 | +427.1% |
| Accrued charges and deferred income | 492/3 | - | €3,000 | +€3,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,382 | €3,897 | -€485 | -11.1% |
| Other operating charges | 640/8 | €553 | €567 | +€14 | +2.5% |
| Gross operating margin | 9900 | €117,227 | €111,905 | -€5,322 | -4.5% |
| Operating profit (loss) | 9901 | €112,292 | €107,441 | -€4,851 | -4.3% |
| Financial income | 75/76B | €6,000 | €8,100 | +€2,100 | +35.0% |
| Recurring financial income | 75 | €6,000 | €8,100 | +€2,100 | +35.0% |
| Financial charges | 65/66B | €1,196 | €898 | -€298 | -24.9% |
| Recurring financial charges | 65 | €1,196 | €898 | -€298 | -24.9% |
| Profit (loss) for the period before taxes | 9903 | €117,095 | €114,643 | -€2,452 | -2.1% |
| Income taxes | 67/77 | €30,385 | €28,485 | -€1,900 | -6.3% |
| Profit (loss) for the period | 9904 | €86,710 | €86,158 | -€552 | -0.6% |
| Profit (loss) for the period to be appropriated | 9905 | €86,710 | €86,158 | -€552 | -0.6% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.